10-K Decoder · All companies

ANI Pharmaceuticals, Inc.

ANIP · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$883M$614M+43.8%
Operating income$111M$580K+19,053%
Net income$77.2M−$20.1M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$291M$228M+27.7%
Operating income$52.4M$36.2M+44.8%
Net income$35.1M$26.6M+32.0%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was ANI Pharmaceuticals's revenue in FY2025?
$883M in FY2025 (Fiscal year ended Dec 31, 2025), +43.8% vs $614M a year earlier, per its 10-K filed Feb 2026.
Was ANI Pharmaceuticals profitable in FY2025?
Yes: net income was $77.2M and operating income $111M in FY2025.
What was ANI Pharmaceuticals's revenue in Q3 2026?
$291M (+27.7% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.